Insider Trading activities at Regeneron Pharmaceuticals, Inc. (REGN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals, Inc. (REGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 872589.

Total stock buying since 2005: $2,475,753,844.
Total stock sales since 2005: $14,586,084,237.
Total stock option exercises since 2005: $1,313,104,322.


35 insiders reported insider trading activities at Regeneron Pharmaceuticals, Inc. (REGN):
Insider trading activities of Rupp Randall
Insider trading activities of Aberman Michael S
Insider trading activities of Roberts William
Insider trading activities of Kolinski Stuart
Insider trading activities of Pitofsky Jason
Insider trading activities of Bassler Bonnie L
Insider trading activities of Mccourt Marion
Insider trading activities of Novartis Pharma Ag
Insider trading activities of Terifay Robert J
Insider trading activities of Zoghbi Huda Y
Insider trading activities of Goldberg Murray A
Insider trading activities of Tessier-lavigne Marc
Insider trading activities of Brown Michael S
Insider trading activities of Ryan Arthur F
Insider trading activities of Sanofi
Insider trading activities of Poon Christine A
Insider trading activities of Ingram Robert Alexander
Insider trading activities of Sanofi-aventis Amerique Du Nord S.n.c.
Insider trading activities of Mccorkle Douglas S
Insider trading activities of Goldstein Joseph L
Insider trading activities of Gilman Alfred G
Insider trading activities of Yancopoulos George
Insider trading activities of Shooter Eric M
Insider trading activities of Sing George L
Insider trading activities of Baker Charles A
Insider trading activities of Schleifer Leonard S
Insider trading activities of Coles N Anthony
Insider trading activities of Larosa Joseph J
Insider trading activities of Van Plew Daniel P
Insider trading activities of Landry Robert E
Insider trading activities of Murphy Andrew J
Insider trading activities of Vagelos P Roy
Insider trading activities of Powchik Peter
Insider trading activities of Fenimore Christopher R.
Insider trading activities of Stahl Neil

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Regeneron Pharmaceuticals, Inc. (REGN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 0 $0 210,364 $207,522,474 616,322 $254,112,622
2023 0 $0 95,808 $78,349,729 273,334 $75,352,970
2022 0 $0 209,705 $142,182,035 469,330 $145,352,340
2021 0 $0 563,365 $351,623,746 2,003,096 $333,732,044
2020 0 $0 24,311,062 $12,445,396,750 1,955,372 $164,839,706
2019 0 $0 416,206 $143,310,975 917,671 $23,311,139
2018 0 $0 427,003 $148,810,340 927,576 $18,552,974
2017 462,141 $212,021,764 137,384 $65,407,790 900,886 $27,301,249
2016 148,669 $62,482,433 20,663 $8,394,544 774,368 $17,691,794
2015 260,466 $131,463,987 420,930 $219,457,542 678,280 $37,168,578
2014 6,498,829 $2,040,580,495 592,551 $211,494,397 1,689,378 $74,072,416
2013 0 $0 979,452 $254,768,275 1,464,593 $33,265,521
2012 0 $0 1,215,019 $159,380,088 2,319,093 $46,475,631
2011 0 $0 729,476 $37,856,945 1,678,597 $36,895,258
2010 1,034,901 $28,971,078 317,918 $9,118,977 332,278 $5,014,862
2009 12,500 $234,087 114,271 $2,249,950 651,002 $5,760,483
2008 0 $0 156,479 $3,272,738 500,195 $4,022,051
2007 0 $0 224,867 $5,157,435 316,441 $3,033,949
2006 0 $0 443,650 $8,648,660 580,125 $5,427,485
2005 0 $0 7,562,667 $83,680,847 135,000 $1,721,250

Table 2. Monthly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-11 0 $0 1,000 $844,610 1,000 $381,400
2024-10 0 $0 1,100 $1,159,032 1,000 $381,400
2024-09 0 $0 1,100 $1,296,705 1,000 $381,400
2024-08 0 $0 26,216 $30,395,175 57,612 $26,774,228
2024-07 0 $0 3,103 $3,328,450 1,137 $423,487
2024-06 0 $0 29,118 $29,696,979 17,568 $9,585,550
2024-05 0 $0 62,158 $60,932,805 206,376 $82,772,373
2024-04 0 $0 350 $337,338 0 $0
2024-03 0 $0 6,241 $5,989,385 20,000 $7,993,200
2024-02 0 $0 23,683 $22,687,937 245,602 $97,413,523
2024-01 0 $0 56,295 $50,854,058 65,027 $28,006,061
2023-12 0 $0 13,673 $11,512,537 75,569 $7,612,739
2023-11 0 $0 7,592 $6,062,677 21,000 $5,790,000
2023-10 0 $0 2,038 $1,708,426 2,038 $778,533
2023-09 0 $0 250 $208,637 0 $0
2023-08 0 $0 32,421 $27,157,374 94,111 $35,629,776
2023-07 0 $0 350 $249,104 0 $0
2023-06 0 $0 550 $404,329 0 $0
2023-05 0 $0 100 $80,546 0 $0
2023-04 0 $0 4,270 $3,433,827 4,170 $2,006,136
2023-03 0 $0 9,478 $7,614,217 16,140 $5,032,094
2023-02 0 $0 25,085 $19,917,308 60,305 $18,503,172
2023-01 0 $0 1 $747 1 $520
2022-12 0 $0 5,758 $4,102,718 5,758 $2,466,727

Table 3. Detailed insider trading at Regeneron Pharmaceuticals, Inc. (REGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-11-01 Mccourt Marion (EVP Commercial) Sale 1,000 844.61 844,610
2024-11-01 Mccourt Marion (EVP Commercial) Option Ex 1,000 381.40 381,400
2024-10-01 Mccourt Marion (EVP Commercial) Sale 1,000 1,054.06 1,054,060
2024-10-01 Mccourt Marion (EVP Commercial) Option Ex 1,000 381.40 381,400
2024-10-01 Ryan Arthur F (Director) Sale 100 1,049.73 104,972
2024-09-03 Mccourt Marion (EVP Commercial) Sale 1,000 1,178.73 1,178,730
2024-09-03 Mccourt Marion (EVP Commercial) Option Ex 1,000 381.40 381,400
2024-09-03 Ryan Arthur F (Director) Sale 100 1,179.76 117,975
2024-08-28 Fenimore Christopher R. (SVP Finance & CFO) Sale 5,680 1,205.76 6,848,711
2024-08-15 Bassler Bonnie L (Director) Sale 756 1,170.00 884,520
2024-08-15 Bassler Bonnie L (Director) Option Ex 756 371.40 280,778
2024-08-15 Poon Christine A (Director) Sale 10,838 1,158.39 12,554,587
2024-08-15 Poon Christine A (Director) Option Ex 10,838 413.33 4,479,670
2024-08-14 Murphy Andrew J (EVP Research) Sale 6,363 1,150.69 7,321,840
2024-08-13 Murphy Andrew J (EVP Research) Option Ex 20,000 399.66 7,993,200
2024-08-07 Pitofsky Jason (VP Controller) Sale 487 1,070.00 521,090
2024-08-07 Pitofsky Jason (VP Controller) Option Ex 487 372.46 181,388
2024-08-02 Bassler Bonnie L (Director) Sale 756 1,115.00 842,940
2024-08-02 Bassler Bonnie L (Director) Option Ex 756 371.40 280,778
2024-08-02 Stahl Neil (EVP Research and Development) Option Ex 23,638 555.67 13,134,927
2024-08-01 Mccourt Marion (EVP Commercial) Sale 1,137 1,060.86 1,206,197
2024-08-01 Mccourt Marion (EVP Commercial) Option Ex 1,137 372.46 423,487
2024-08-01 Ryan Arthur F (Director) Sale 100 1,090.90 108,195
2024-07-11 Larosa Joseph J (EVP General Counsel and Secret) Sale 1,866 1,088.95 2,031,980
2024-07-01 Mccourt Marion (EVP Commercial) Sale 1,137 1,047.11 1,190,564
2024-07-01 Mccourt Marion (EVP Commercial) Option Ex 1,137 372.46 423,487
2024-07-01 Ryan Arthur F (Director) Sale 100 1,059.06 105,906
2024-06-24 Bassler Bonnie L (Director) Sale 756 1,062.00 802,872
2024-06-24 Bassler Bonnie L (Director) Option Ex 756 371.40 280,778
2024-06-24 Larosa Joseph J (EVP General Counsel and Secret) Option Ex 14,450 555.67 8,029,431
2024-06-14 Brown Michael S (Director) Sale 1,535 1,040.00 1,596,400
2024-06-14 Brown Michael S (Director) Option Ex 1,535 625.60 960,296
2024-06-12 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Sale 16,149 1,019.06 16,456,848
2024-06-11 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Sale 9,064 1,015.66 9,205,942
2024-06-06 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Sale 787 1,015.02 798,820
2024-06-05 Bassler Bonnie L (Director) Sale 827 1,011.00 836,097
2024-06-05 Bassler Bonnie L (Director) Option Ex 827 380.95 315,045
2024-05-28 Brown Michael S Sale 1,172 974.86 1,142,535
2024-05-28 Brown Michael S Option Ex 1,172 625.60 733,203
2024-05-21 Larosa Joseph J (EVP General Counsel and Secret) Sale 1,865 994.90 1,855,488
2024-05-17 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Sale 22,830 979.64 22,365,295
2024-05-15 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Sale 10,941 984.03 10,766,239
2024-05-14 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Sale 25,000 979.63 24,490,750
2024-05-13 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Option Ex 203,204 399.66 81,212,510
2024-05-03 Sing George L (Director) Option Ex 2,000 413.33 826,660
2024-05-01 Mccourt Marion (EVP Commercial) Sale 250 889.41 222,352
2024-05-01 Ryan Arthur F (Director) Sale 100 901.47 90,146
2024-04-01 Mccourt Marion (EVP Commercial) Sale 250 964.73 241,182
2024-04-01 Ryan Arthur F (Director) Sale 100 961.56 96,156
2024-03-14 Murphy Andrew J (EVP Research) Sale 5,783 958.88 5,545,197
2024-03-13 Murphy Andrew J (EVP Research) Option Ex 20,000 399.66 7,993,200
2024-03-01 Mccourt Marion (EVP Commercial) Sale 358 967.50 346,365
2024-03-01 Ryan Arthur F (Director) Sale 100 978.23 97,823
2024-02-26 Bassler Bonnie L (Director) Sale 854 979.25 836,279
2024-02-26 Bassler Bonnie L (Director) Option Ex 854 391.92 334,699
2024-02-26 Larosa Joseph J (EVP General Counsel and Secret) Sale 1,000 990.00 990,000
2024-02-26 Sing George L (Director) Sale 1,000 992.50 992,500
2024-02-26 Sing George L (Director) Option Ex 1,000 413.33 413,330
2024-02-23 Sing George L (Director) Sale 500 985.00 492,500
2024-02-23 Sing George L (Director) Option Ex 500 413.33 206,665
2024-02-22 Larosa Joseph J (EVP General Counsel and Secret) Sale 1,000 967.65 967,650
2024-02-22 Sing George L (Director) Sale 3,000 965.00 2,895,000
2024-02-22 Sing George L (Director) Option Ex 3,000 413.33 1,239,990
2024-02-15 Yancopoulos George (Bd. Co-Chair, President & CSO) Option Ex 172,723 399.66 69,030,474
2024-02-09 Fenimore Christopher R. (SVP Finance & CFO) Sale 4,919 952.92 4,687,428
2024-02-09 Van Plew Daniel P (EVP & General Mgr, Industrial) Option Ex 35,375 376.93 13,333,898
2024-02-09 Sing George L (Director) Sale 500 955.00 477,500
2024-02-09 Sing George L (Director) Option Ex 500 413.33 206,665
2024-02-08 Sing George L (Director) Sale 500 945.00 472,500
2024-02-08 Sing George L (Director) Option Ex 500 413.33 206,665
2024-02-07 Larosa Joseph J (EVP General Counsel and Secret) Sale 1,000 950.00 950,000
2024-02-07 Stahl Neil (EVP Research and Development) Sale 8,037 950.41 7,638,469
2024-02-05 Mccourt Marion (EVP Commercial) Sale 1,000 934.71 934,710
2024-02-02 Landry Robert E (EVP Finance CFO) Option Ex 400 378.98 151,592
2024-02-02 Stahl Neil (EVP Research and Development) Option Ex 30,750 399.66 12,289,545
2024-02-01 Mccourt Marion (EVP Commercial) Sale 273 945.61 258,151
2024-02-01 Ryan Arthur F (Director) Sale 100 952.51 95,250
2024-01-31 Landry Robert E (EVP Finance CFO) Option Ex 400 378.98 151,592
2024-01-30 Bassler Bonnie L (Director) Sale 827 959.00 793,093
2024-01-30 Bassler Bonnie L (Director) Option Ex 827 380.95 315,045
2024-01-24 Landry Robert E (EVP Finance CFO) Option Ex 500 378.98 189,490
2024-01-23 Fenimore Christopher R. (SVP Controller) Option Ex 10,000 477.67 4,776,650
2024-01-23 Landry Robert E (EVP Finance CFO) Option Ex 1,100 378.98 416,878
2024-01-23 Goldstein Joseph L (Director) Sale 2,707 950.00 2,571,650
2024-01-23 Goldstein Joseph L (Director) Option Ex 2,707 625.60 1,693,499
2024-01-17 Landry Robert E (EVP Finance CFO) Option Ex 500 378.98 189,490
2024-01-12 Landry Robert E (EVP Finance CFO) Option Ex 800 378.98 303,184
2024-01-04 Landry Robert E (EVP Finance CFO) Option Ex 500 378.98 189,490
2024-01-03 Fenimore Christopher R. (SVP Controller) Option Ex 10,000 477.67 4,776,650
2024-01-03 Bassler Bonnie L (Director) Sale 826 914.00 754,964
2024-01-03 Bassler Bonnie L (Director) Option Ex 826 380.95 314,664
2024-01-03 Landry Robert E (EVP Finance CFO) Option Ex 1,100 378.98 416,878
2024-01-03 Larosa Joseph J (EVP General Counsel and Secret) Option Ex 34,000 399.66 13,588,440
2024-01-02 Zoghbi Huda Y (Director) Sale 1,117 900.00 1,005,300
2024-01-02 Zoghbi Huda Y (Director) Option Ex 1,117 391.92 437,774
2024-01-02 Mccourt Marion (EVP Commercial) Sale 274 873.91 239,451
2024-01-02 Landry Robert E (EVP Finance CFO) Option Ex 650 378.98 246,337
2024-01-02 Yancopoulos George (Bd. Co-Chair, President & CSO) Sale 33,696 900.00 30,326,400
2023-12-28 Landry Robert E (EVP Finance CFO) Option Ex 850 378.98 322,133
2023-12-27 Fenimore Christopher R. (SVP Controller) Sale 2,448 856.71 2,097,226
2023-12-27 Landry Robert E (EVP Finance CFO) Option Ex 750 378.98 284,235
2023-12-27 Brown Michael S (Director) Sale 2,049 898.00 1,840,002
2023-12-27 Brown Michael S (Director) Option Ex 2,049 482.68 989,011
2023-12-22 Fenimore Christopher R. (SVP Controller) Sale 250 846.27 211,567
2023-12-21 Fenimore Christopher R. (SVP Controller) Sale 1,680 843.94 1,417,819
2023-12-13 Bassler Bonnie L (Director) Sale 610 870.00 530,700
2023-12-13 Bassler Bonnie L (Director) Option Ex 610 376.69 229,780
2023-12-13 Landry Robert E (EVP Finance CFO) Option Ex 1,000 378.98 378,980
2023-12-11 Yancopoulos George (Bd. Co-Chair, President & CSO) Option Ex 25,155 .00 0
2023-12-11 Schleifer Leonard S (Bd. Co-Chair, President & CEO) Option Ex 25,155 .00 0
2023-12-05 Murphy Andrew J (EVP Research) Sale 6,536 816.00 5,333,369
2023-12-04 Murphy Andrew J (EVP Research) Option Ex 20,000 270.43 5,408,600
2023-12-01 Ryan Arthur F (Director) Sale 100 818.55 81,854
2023-11-14 Murphy Andrew J (EVP Research) Sale 6,492 800.35 5,195,878
2023-11-13 Murphy Andrew J (EVP Research) Option Ex 20,000 270.43 5,408,600
2023-11-07 Ryan Arthur F (Director) Sale 100 828.90 82,889
2023-11-01 Mccourt Marion (EVP Commercial) Sale 1,000 783.91 783,910
2023-11-01 Mccourt Marion (EVP Commercial) Option Ex 1,000 381.40 381,400
2023-10-13 Zoghbi Huda Y (Director) Sale 1,000 850.00 850,000
2023-10-13 Zoghbi Huda Y (Director) Option Ex 1,000 391.92 391,920
2023-10-02 Mccourt Marion (EVP Commercial) Sale 1,038 827.00 858,426
2023-10-02 Mccourt Marion (EVP Commercial) Option Ex 1,038 372.46 386,613
2023-09-01 Mccourt Marion (EVP Commercial) Sale 250 834.55 208,637
2023-08-24 Van Plew Daniel P (EVP & General Mgr, Industrial) Sale 6,197 839.93 5,205,046
2023-08-23 Fenimore Christopher R. (SVP Controller) Option Ex 7,000 399.66 2,797,620
2023-08-23 Landry Robert E (EVP Finance CFO) Sale 223 844.00 188,212
2023-08-23 Van Plew Daniel P (EVP & General Mgr, Industrial) Option Ex 23,125 381.40 8,819,875
2023-08-23 Poon Christine A (Director) Sale 12,280 839.53 10,309,477
2023-08-23 Poon Christine A (Director) Option Ex 12,280 273.67 3,360,667
2023-08-22 Stahl Neil (EVP Research and Development) Sale 11,665 841.37 9,814,546
2023-08-21 Bassler Bonnie L (Director) Sale 853 829.00 707,137
2023-08-21 Bassler Bonnie L (Director) Option Ex 853 391.92 334,307
2023-08-21 Stahl Neil (EVP Research and Development) Option Ex 50,000 399.66 19,983,000
2023-08-10 Bassler Bonnie L (Director) Sale 853 789.00 673,017
2023-08-10 Bassler Bonnie L (Director) Option Ex 853 391.92 334,307
2023-08-01 Mccourt Marion (EVP Commercial) Sale 250 744.66 186,165
2023-08-01 Ryan Arthur F (Director) Sale 100 737.75 73,774
2023-07-03 Mccourt Marion (EVP Commercial) Sale 250 710.09 177,522
2023-07-03 Ryan Arthur F (Director) Sale 100 715.83 71,582
2023-06-01 Mccourt Marion (EVP Commercial) Sale 250 736.00 184,000
2023-06-01 Ryan Arthur F (Director) Sale 200 734.44 146,886
2023-05-01 Ryan Arthur F (Director) Sale 100 805.46 80,546
2023-04-21 Brown Michael S (Director) Sale 3,070 798.42 2,451,149
2023-04-21 Brown Michael S (Director) Option Ex 3,070 520.01 1,596,430
2023-04-03 Mccourt Marion (EVP Commercial) Sale 1,100 818.80 900,680
2023-04-03 Mccourt Marion (EVP Commercial) Option Ex 1,100 372.46 409,706
2023-04-03 Ryan Arthur F (Director) Sale 100 819.99 81,998
2023-03-28 Landry Robert E (EVP Finance CFO) Sale 1,007 822.95 828,710
2023-03-27 Landry Robert E (EVP Finance CFO) Sale 183 824.12 150,813
2023-03-27 Landry Robert E (EVP Finance CFO) Option Ex 3,800 380.45 1,445,710

Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals, Inc. (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.